Browsing Tag
Inc.
380 posts
What the RIDGE-1 interim results reveal about the future of cardiac gene therapy in ARVC
Could TN-401 reshape inherited heart disease treatment? Explore what Tenaya Therapeutics, Inc.’s RIDGE-1 data means for cardiac gene therapy.
BlackRock could anchor SpaceX IPO demand as valuation talk reaches $1.75tn
SpaceX may test IPO history. BlackRock’s reported billions could decide whether private-market hype survives public scrutiny.
Muscle Milk just changed its formula, but PepsiCo may be chasing something much bigger
Protein is booming, but consumers are confused. PepsiCo’s Muscle Milk reset turns simplicity into a new functional beverage strategy.
Can Hancock Whitney turn the One Florida Bank acquisition into a larger Florida growth platform?
Find out why Hancock Whitney Corporation’s One Florida Bank acquisition could reshape its Florida growth strategy and regional banking outlook.
Why Honey Badger Silver Inc. is trying to reposition itself within the next North American silver and critical minerals cycle
Find out why Honey Badger Silver Inc.’s Prairie Creek acquisition could reshape its exposure to silver scarcity and critical minerals demand.
Could Mobix Labs, Inc. evolve from defense electronics supplier into strategic minerals operator?
Could Mobix Labs, Inc. become a strategic minerals player? Discover how its SPD acquisition plan could reshape defense and AI supply chains.
Why Sumitomo Forestry Co., Ltd.’s $47-per-share Tri Pointe Homes bet could shake up U.S. housing
Find out how Sumitomo Forestry’s Tri Pointe Homes acquisition could reshape U.S. homebuilding scale, strategy, and competition today!
What the Acclaim cochlear implant’s pivotal data could mean for the broader hearing device market
Could Envoy Medical, Inc.’s Acclaim implant reshape the hearing-device market? Explore the regulatory, commercial, and industry implications.
Could oral elraglusib emerge as a combination backbone for RAS-targeted cancer therapies?
Actuate Therapeutics, Inc. is advancing oral elraglusib to target resistance biology in cancer. Discover what this means for oncology markets.
Why Anthropic wants Claude powering the next wave of American solopreneurs
Anthropic, Workday, and LISC are backing AI-powered solopreneurs. Find out why Claude could become future small-business infrastructure.